MedPath
FDA Approval

SENSORCAINE

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 30, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Bupivacaine(2.5 mg in 1 mL)
Epinephrine(0.005 mg in 1 mL)

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Fresenius Kabi USA, LLC

Fresenius Kabi USA, LLC

023648251

Products4

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SENSORCAINE MPF

Product Details

NDC Product Code
63323-468
Application Number
ANDA070966
Marketing Category
ANDA (C73584)
Route of Administration
INFILTRATION, EPIDURAL, INTRACAUDAL, PERINEURAL
Effective Date
April 30, 2023
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.2 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 2.5 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.005 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

SENSORCAINE

Product Details

NDC Product Code
63323-461
Application Number
ANDA070967
Marketing Category
ANDA (C73584)
Route of Administration
INFILTRATION, PERINEURAL
Effective Date
April 30, 2023
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.2 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACTQuantity: 1 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 2.5 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.005 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT

SENSORCAINE

Product Details

NDC Product Code
63323-463
Application Number
ANDA070968
Marketing Category
ANDA (C73584)
Route of Administration
PERINEURAL
Effective Date
April 30, 2023
CITRIC ACID MONOHYDRATEInactive
Code: 2968PHW8QPClass: IACTQuantity: 0.2 mg in 1 mL
SODIUM METABISULFITEInactive
Code: 4VON5FNS3CClass: IACTQuantity: 0.5 mg in 1 mL
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
METHYLPARABENInactive
Code: A2I8C7HI9TClass: IACTQuantity: 1 mg in 1 mL
Code: 30Q7KI53AKClass: ACTIMQuantity: 0.005 mg in 1 mL
Code: 7TQO7W3VT8Class: ACTIRQuantity: 5 mg in 1 mL

SENSORCAINE MPF

Product Details

NDC Product Code
63323-472
Application Number
ANDA070554
Marketing Category
ANDA (C73584)
Route of Administration
EPIDURAL, RETROBULBAR
Effective Date
April 30, 2023
SODIUM CHLORIDEInactive
Code: 451W47IQ8XClass: IACTQuantity: 8 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 7TQO7W3VT8Class: ACTIRQuantity: 7.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath